Heat Biologics (HTBX) Shares Hit on Adverse HS-410 Combo Phase 2 Data in Invasive Bladder Cancer
Go back to Heat Biologics (HTBX) Shares Hit on Adverse HS-410 Combo Phase 2 Data in Invasive Bladder CancerHEAT BIOLOGICS (NASDAQ: HTBX) | Delayed: 2.83 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.83 | 52 Week High | $4.71 | |||
Open | $2.83 | 52 Week Low | $0.40 | |||
Day High | $2.83 | P/E | N/A | |||
Day Low | $2.83 | EPS | $-0.50 | |||
Volume | 49,118 |